MASTERMIND: Bringing Microbial Diagnostics to the Clinic.
Journal Article (Journal Article)
New diagnostics are urgently needed to address emerging antimicrobial resistance. The Antibacterial Resistance Leadership Group proposes a strategy called MASTERMIND (Master Protocol for Evaluating Multiple Infection Diagnostics) for advancement of infectious diseases diagnostics. The goal of this strategy is to generate the data necessary to support US Food and Drug Administration clearance of new diagnostic tests by promoting research that might not have otherwise been feasible with conventional trial designs. MASTERMIND uses a single subject's sample(s) to evaluate multiple diagnostic tests at the same time, providing efficiencies of specimen collection and characterization. MASTERMIND also offers central trial organization, standardization of methods and definitions, and common comparators.
Full Text
- Published version (via Digital Object Identifier)
- Pubmed Central version
- Open Access Copy from Duke
- Link to Item
Duke Authors
Cited Authors
- Patel, R; Tsalik, EL; Petzold, E; Fowler, VG; Klausner, JD; Evans, S; Antibacterial Resistance Leadership Group (ARLG),
Published Date
- February 1, 2017
Published In
- Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Volume / Issue
- 64 / 3
Start / End Page
- 355 - 360
PubMed ID
- 27927867
Pubmed Central ID
- PMC5894935
Electronic International Standard Serial Number (EISSN)
- 1537-6591
Digital Object Identifier (DOI)
- 10.1093/cid/ciw788
Language
- eng
Conference Location
- United States